Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CV's earnings per share without non-recurring items for the
six
months ended in Dec. 2024 was $2.29.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was $2.29.
During the past 12 months, Corporativo FraguaB de CV's average earnings per share (NRI) Growth Rate was 9.00% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 23.10% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 25.00% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 18.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Corporativo FraguaB de CV's EPS without NRI or its related term are showing as below:
CGSBF'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 2.3 Med: 14.4 Max: 30.7
Current: 23.1
During the past 13 years, Corporativo FraguaB de CV's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 30.70% per year. The lowest was 2.30% per year. And the median was 14.40% per year.
CGSBF's 3-Year EPS without NRI Growth Rate is ranked better than 63.26% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.7
vs CGSBF: 23.10
Corporativo FraguaB de CV (OTCPK:CGSBF) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Corporativo FraguaB de CV EPS without NRI Related Terms
Corporativo FraguaB de CV EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV EPS without NRI Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's PE Ratio without NRI falls into.
Corporativo FraguaB de CV EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $2.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV (CGSBF) has a EPS without NRI of $2.29 as of Dec. 2024. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Corporativo FraguaB de CV and its competitors. According to the industry distribution chart, Corporativo FraguaB de CV ranks #187 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 36.7%.
Is Corporativo FraguaB de CV's EPS without NRI too high?
Corporativo FraguaB de CV's current EPS without NRI is $2.29. The Healthcare Providers & Services industry median EPS without NRI is 11.70. Corporativo FraguaB de CV's value of $2.29 is 80.4% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #187 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #187 out of 509 companies for EPS without NRI. This puts Corporativo FraguaB de CV in the upper half of its industry. The industry median EPS without NRI is 11.70. Corporativo FraguaB de CV's value of $2.29 is 80.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.70, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current EPS without NRI of $2.29 is 80.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current EPS without NRI is $2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current EPS without NRI of $2.29. The stock's GF Value™ is $43.12, compared to a current price of $29.66 — trading 31.2% below its estimated fair value. The current EPS without NRI is $2.29 and 80.4% below the Healthcare Providers & Services industry median of 11.70. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current EPS without NRI is $2.29 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 31.2% below its estimated GF Value™ of $43.12.
Key valuation signals for CGSBF:
EPS without NRI: $2.29
GF Value™: $43.12 vs. price of $29.66 (31.2% below fair value)
Industry Position: 80.4% below the Healthcare Providers & Services median (#187 of 509)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for CGSBF
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
